Professor of Medicine
Vanderbilt University School of Medicine
Tina Hartert, M.D., M.P.H., is Professor of Medicine, Lulu H. Owen Endowed Chair in Medicine, Director of the Center for Asthma Research, and Assistant Vice President for Translational Science. Dr. Hartert is a graduate of Brown University (BA), Vanderbilt University Medical School (MD and MPH), completed an internal medicine residency and Osler chief residency at Johns Hopkins, and a fellowship in Pulmonary & Critical Care Medicine at Vanderbilt. Dr. Hartert is a respiratory epidemiologist whose focus is in primary and secondary prevention of asthma and allergic diseases. She is the Director of the Center for Asthma Research, a highly multidisciplinary translational research group. With a focus on identifying modifiable exposures conferring extreme susceptibility to asthma and allergic diseases, the work of the Center is at the crossroads between epidemiology, translational science and the clinical world, aiming to identify and bring early life asthma prevention efforts to clinical use. Some of her team’s major scientific advances include: establishing multi-level evidence assessing the causal relationship of respiratory syncytial virus with asthma development, identification of a vitamin E isoform that modulates allergic airway inflammation and asthma risk, delineation of novel protective bacterial genera and local immune responses of the upper airway that are associated with asthma development, and establishment of asthma as a risk-factor for vaccine-preventable infections. Her research contributions have been recognized by election to the American Society of Clinical Investigation (ASCI) and the Association of American Physicians (AAP). In addition, she has served as a member of a number of NIH expert panels, including the National Asthma Expert Panel that establishes national asthma guidelines. In addition, her research group has a heavy focus on research mentoring and the development of the next generation of translational investigators. In 2015 Dr. Hartert was awarded the inaugural Vanderbilt award in research mentoring of clinical-translational scientists, and in 2019 the award for mentoring post-doctoral fellows.
Disclosure: Pfizer (Individual(s) Involved: Self): Advisor or Review Panel member; Sanofi-Aventis (Individual(s) Involved: Self): Advisor or Review Panel member
Saturday, October 24, 2020
10:00am – 11:15am EDT